Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Vaxart, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +1 vs. Q2 2024
- Shares held
- 37.6M
- −1.19M (−3.1%) vs. Q2 2024
- Total value
- $31.9M
- +$6.03M (+23.3%) vs. Q2 2024
- New holders
- 18
- 15 more added
- Sold out
- 17
- 26 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VXRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $39.0K |
| Q1 2026 | 5 | $34.2K |
| Q4 2025 | 5 | $22.2K |
| Q3 2025 | 17 | $839.9K |
| Q2 2025 | 98 | $10.3M |
| Q1 2025 | 92 | $11.1M |
| Q4 2024 | 93 | $23.7M |
| Q3 2024 | 100 | $31.9M |
| Q2 2024 | 100 | $27.0M |
| Q1 2024 | 104 | $52.3M |
| Q4 2023 | 87 | $9.38M |
| Q3 2023 | 96 | $13.9M |
| Q2 2023 | 111 | $21.1M |
| Q1 2023 | 109 | $25.8M |
| Q4 2022 | 132 | $42.6M |
| Q3 2022 | 143 | $110.7M |
| Q2 2022 | 146 | $155.6M |
| Q1 2022 | 148 | $226.3M |
| Q4 2021 | 147 | $267.9M |
| Q3 2021 | 141 | $297.5M |
| Q2 2021 | 143 | $260.6M |
| Q1 2021 | 159 | $195.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vaxart, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −1,250,000−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −945,568−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −847,631−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −39,212−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Private Portfolio Partners LLC | 0 | $0 | 0.00% | −27,170−100.0% | Sold out |
| RPg Family Wealth Advisory, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Kingswood Wealth Advisors, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Moors & Cabot, Inc. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,105−100.0% | Sold out |
| Tamar Securities, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,328−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −11,312−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −5,264−100.0% | Sold out |
| Financial Network Wealth Advisors LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Abich Financial Wealth Management LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |